Navigation Links
Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients

Professor Kaspar Rossing and his colleagues from the Steno Diabetes Center, Denmark has found that supplementation of Spironolactone drug to diabetes patients taking //antihypertensive drugs, reduced the chances of developing kidney failure and reduced blood pressure and albumin protein in urine of these patients.

Diabetes patients with high blood pressure are more prone to kidney diseases. Supplementation of Spironolactone has found to inhibit aldosterone, as this hormone increase the urinary protein levels leading to kidney dysfunction. Most of the hypertensive drugs may be useful in diabetic patients already having kidney damage, but does not protect these patients prior to occurrence. The study was conducted in 21 diabetic patients with type 2 diabetes, the patients were asked to take spironolactone for 8 weeks and after the treatment, the urinary albumin levels of the study patients dropped by 33 % and also reduced their upper and lower blood pressure. Though one patient developed low potassium levels the patient recovered rapidly. Further research is required regarding the supplementation of spironolactone.

[SOURCE: Diabetes Care, September 2005.]
'"/>




Page: 1

Related medicine news :

1. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
2. London Hospital Provides Specialized Care For Pregnant Women
3. Breastfeeding Provides Added Protection To Babies
4. Far East Provides A Path To Contain Bird Flu
5. Direct To Home: Television Provides Powerful Fillip to Smoking Cessation Campaigns.
6. Latest Version of Echocardiography Provides Improved Pictures of the Heart
7. Hearing May Be Regained: Research Provides Hopes
8. Study Provides Evidence That Obesity Leads To A More Aggressive Ovarian Cancer
9. Food Safety Extension Specialist Provides Spinach E. coli Advice
10. A New Approach to Heart Bypass Surgery Provides Patients with One-stop Shopping
11. Rajasthan Government Provides Free Dengue Tests for Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... ... announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to ... Medical Informatics . , Results of the comparative usability study demonstrate that a ...
(Date:12/8/2016)... ... 2016 , ... With the increasing demand for dental implants, the National Association ... to inform dentists and patients about the safety issues related to dental restorations. According ... the U.S. is projected to reach $6.4 billion in 2018 with more than 30 ...
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into ... claim in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th ... According to the study, medical payments per claim in California decreased 4 percent in ...
(Date:12/8/2016)... Rock, AR (PRWEB) , ... December 08, 2016 ... ... providing insurance and financial planning services from offices headquartered in Little Rock, has ... Food Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition of the ... Application, Usability - Forecast to 2025" report to their offering. ... , , ... grow at a CAGR of around 3.2% from 2015 to 2025. ... advancements in extracellular microelectrode arrays and intracellular microelectrodes, research in left-to-right ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
Breaking Medicine Technology: